What Are Clinical Trials for MASH? Clinical trials for MASH are research studies that evaluate potential new treatments for a form of liver disease called metabolic dysfunction-associated ...
Semaglutide is a glucagon-like peptide-1 receptor (GLP-1) medication primarily used to manage obesity and diabetes. The U.S. Food and Drug Administration (FDA) also has approved it under the brand ...
Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...